Search Results - "Fecteau, R.E."

Efficacy of Oligometastasis Directed Stereotactic Body Radiation Therapy in De Novo Oligometastatic Prostate Cancer by LaBella, D., Huang, C.C., Fecteau, R.E.

“…Approximately 10% of patients diagnosed with prostate cancer have evidence of metastasis at the time of presentation. Historically, management was restricted…”
Get full text

Efficacy of Oligorecurrence Directed Stereotactic Body Radiation Therapy in Oligorecurrent Prostate Cancer by LaBella, D., Huang, C.C., Fecteau, R.E.

“…Recent retrospective and phase II randomized studies have evaluated the role of metastasis directed therapy for oligorecurrent prostate cancer, with a focus on…”
Get full text

Deletion of the Tumor Suppressor Gene PTEN in ETS-Fusion Positive Prostate Cancer Identifies Patients with High Risk Pathology That May Benefit from Adjuvant Radiation by Fecteau, R.E., Liu, D., Barbieri, C.E., Nagar, H.

Get full text

Developing a Translational Platform for Therapeutic Delivery of Image-Guided Ultra-Hypofractionated Prostate-Directed Radiotherapy in Orthotopic Prostate Cancer Models by Marciscano, A.E., Basourakos, S.P., Lin, K.J., Fecteau, R.E., Kraynak, J., Khani, F., Nagar, H., Barbieri, C.E.

Get full text

Initial Dosimetric Outcomes and Treatment Related Toxicities Using Stereotactic MRI-Guided Radiation Therapy (SMART) for Unresectable Pancreatic Cancer at a Single Institution by Fecteau, R.E., Pennell, R., Farjam, R.F., Ng, J.

Get full text

Initial Outcomes And Treatment-Associated Toxicities Using Stereotactic MRI-Guided Adaptive Radiation Therapy For Pancreatic Cancer Patients Treated At A Single Institution by Kaylor, K., Fecteau, R.E., Pennell, R., Chen, S.L., Balogun, O., Cardenes, H.R.R., Golden, E.B., Ng, J.

Get full text